RATA: A novel class A carbapenemase with broad geographic distribution and potential for global spread

  09 May 2024

Carbapenem resistance is a global health issue, primarily due to carbapenemase production. A new carbapenemase, RATA, was discovered in Riemerella anatipestifer isolates, which shares a 52% amino acid sequence identity with other β-lactamases. RATA hydrolyzes penicillins, cephalosporins, monobactams, cephamycins, and carbapenems and can be inhibited by β-lactamase inhibitors. Bioinformatic analysis revealed 46 blaRATA-like genes encoding 27 variants, primarily from marine environments. blaRATA orthologue genes were found on Flavobacteriaceae chromosomes, sharing similar GC content. The study suggests RATA is a new chromosome-encoded class A carbapenemase.

Author(s): Hongyan Luo et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed